ABSTRACT
Objectives Insight is an important predictor of quality of life in Huntington’s disease and other neurodegenerative conditions. However, estimating insight with traditional methods such as questionnaires is challenging and subject to limitations. This cross-sectional study experimentally quantified metacognitive insight into cognitive performance in Huntington’s disease gene-carriers.
Methods We dissociated perceptual decision-making performance and metacognitive insight into performance in healthy controls (n=29), premanifest (n=19) and early-manifest (n=10) Huntington’s disease gene-carriers. Insight was operationalised as the degree to which a participant’s confidence in their performance was informative of their actual performance (metacognitive efficiency) and estimated using a computational model (HMeta-d).
Results We found that pre and early-manifest Huntington’s disease gene-carriers were impaired in making perceptual decisions compared to controls. Gene-carriers required more evidence in favour of the correct choice to achieve similar performance and perceptual impairments were increased in those with manifest disease. Surprisingly, despite marked perceptual impairments, Huntington’s disease gene-carriers retained metacognitive insight into their perceptual performance. This was the case after controlling for confounding variables and regardless of disease stage.
Conclusion We report for the first time a dissociation between impaired cognition and intact metacognition (trial-by-trial insight) in the early-stages of a neurodegenerative disease. This unexpected finding contrasts with the prevailing assumption that cognitive deficits are associated with impaired insight. Future studies should investigate how intact metacognitive insight could be used by some early Huntington’s disease gene-carriers to positively impact their quality of life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
S.R.H is funded by the Medical Research Council (MR/N013867/1). A.J.W is funded by the Parasol Foundation Trust through the Cambridge Trust and by the Donald R. Shepherd award from the University of California at Los Angeles. S.L.M. is supported by the Huntington's Disease Association and by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). R.A.B is supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Oxford South Central-C Research Ethics Committee and the Medical Health Research Authority in the United Kingdom.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
A typing error was corrected in the reporting of a statistical value on line 273 (R-squared and p-value for regression analysis of mean confidence). This did not alter the finding or conclusion made from it. Grant code information was added.
Data Availability
The task and HMeta-d toolbox for implementation in Matlab can be accessed thanks to Meta-Lab, UCL (https://github.com/metacoglab). Data and scripts used for data analysis in this study are available (https://github.com/samrchewitt/HD_perception_metacognition). Tutorials and installation guides for the HDDM toolbox (http://ski.clps.brown.edu/hddm_docs/). We encourage readers to contact the corresponding authors if they would like advice on applying or replicating this approach.
https://github.com/samrchewitt/HD_perception_metacognition
https://github.com/metacoglab/HMeta-d
